Current Study: S4

Purpose:
• To provide information on the safety and tolerability following a multiple dose administration of the study drug.
• This study is for research purposes only and is not intended to treat any medical condition.

Method of Administration:
Daily oral dosing for 28 days

Investigator: Thomas Marbury, MD

To qualify:

• 18 to 80 years old
• Available for clinical follow-ups for the duration of the study
• No COVID vaccination or any other vaccination or plan to receive a COVID vaccination or any other vaccination within 28 days of dosing or during the study.
• Meet other requirements

Length/Duration:
• 1 screening visit to determine eligibility
• 5 outpatient visits
• 2 phone calls

Location: 5055 South Orange Avenue, Orlando, FL 32809

Qualified participants will receive study medication, study related exams and laboratory tests at no charge

Compensation:
Qualified participants will be compensated up to $800 for study-related time and travel

Whom to Contact Recruitment Department: 407-240-7876